Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Mindfulness-Based Blood Pressure Reduction (MB-BP): Stage 1 single-arm clinical trial.

Loucks EB, Nardi WR, Gutman R, Kronish IM, Saadeh FB, Li Y, Wentz AE, Webb J, Vago DR, Harrison A, Britton WB.

PLoS One. 2019 Nov 27;14(11):e0223095. doi: 10.1371/journal.pone.0223095. eCollection 2019.

2.

The power of mentorship.

Lewis CP, Johnson BH, Donnell C, Phillips T, Jackson D, Backus M, Payne A, Greenwell RW, Wentz A.

Nurs Manage. 2019 Jul;50(7):38-44. doi: 10.1097/01.NUMA.0000558524.37370.ce.

PMID:
31246653
3.

Blood Donation, Sexual Practices, and Self-Perceived Risk for HIV in the United States Among Young Adult Men Who Have Sex With Men.

Wentz AE, Merchant RC, Clark MA, Liu T, Rosenberger JG, Bauermeister JA, Mayer KH.

Public Health Rep. 2019 Jan/Feb;134(1):36-46. doi: 10.1177/0033354918815182. Epub 2018 Dec 7.

4.

Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.

Yin LX, D'Souza G, Westra WH, Wang SJ, van Zante A, Zhang Y, Rettig EM, Ryan WR, Ha PK, Wentz A, Koch W, Eisele DW, Fakhry C.

Laryngoscope. 2018 Aug;128(8):E287-E295. doi: 10.1002/lary.27130. Epub 2018 Mar 14.

PMID:
29536542
5.

Rethinking ethnicity, fetal growth and customised charts.

Braun L, Wentz AE.

BJOG. 2018 May;125(6):710. doi: 10.1111/1471-0528.14937. Epub 2017 Oct 16. No abstract available.

6.

Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment.

Zhang Y, Waterboer T, Haddad RI, Miles BA, Wentz A, Gross ND, Fakhry C, Quon H, Lorch JH, Gourin CG, Clayburgh D, Misiukiewicz KJ, Richmon JD, Andersen PE, Posner MR, D'Souza G.

Oral Oncol. 2017 Apr;67:77-82. doi: 10.1016/j.oraloncology.2017.02.004. Epub 2017 Feb 15.

7.

The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.

Fakhry C, Westra WH, Wang SJ, van Zante A, Zhang Y, Rettig E, Yin LX, Ryan WR, Ha PK, Wentz A, Koch W, Richmon JD, Eisele DW, D'Souza G.

Cancer. 2017 May 1;123(9):1566-1575. doi: 10.1002/cncr.30353. Epub 2017 Feb 27.

8.

Differences in the Prevalence of Human Papillomavirus (HPV) in Head and Neck Squamous Cell Cancers by Sex, Race, Anatomic Tumor Site, and HPV Detection Method.

D'Souza G, Westra WH, Wang SJ, van Zante A, Wentz A, Kluz N, Rettig E, Ryan WR, Ha PK, Kang H, Bishop J, Quon H, Kiess AP, Richmon JD, Eisele DW, Fakhry C.

JAMA Oncol. 2017 Feb 1;3(2):169-177. doi: 10.1001/jamaoncol.2016.3067.

PMID:
27930766
9.

The association of medication use with clearance or persistence of oral HPV infection.

Lam JO, Sugar EA, Cranston RD, Weber KM, Burk RD, Wiley DJ, Reddy S, Margolick JB, Strickler HD, Wentz A, Jacobson L, Coles CL, Bream JH, Rositch AF, Guo Y, Xiao W, Gillison ML, D'Souza G.

Cancer Causes Control. 2016 Dec;27(12):1491-1498. Epub 2016 Nov 1.

10.

Using a Mystery-Caller Approach to Examine Access to Prostate Cancer Care in Philadelphia.

Pollack CE, Ross ME, Armstrong K, Branas CC, Rhodes KV, Bekelman JE, Wentz A, Stillson C, Radhakrishnan A, Oyeniran E, Grande D.

PLoS One. 2016 Oct 10;11(10):e0164411. doi: 10.1371/journal.pone.0164411. eCollection 2016.

11.

Association of serum cytokines with oral HPV clearance.

Lam JO, Bream JH, Sugar EA, Coles CL, Weber KM, Burk RD, Wiley DJ, Cranston RD, Reddy S, Margolick JB, Strickler HD, Wentz A, Jacobson L, Guo Y, Xiao W, Gillison ML, D'Souza G.

Cytokine. 2016 Jul;83:85-91. doi: 10.1016/j.cyto.2016.04.002. Epub 2016 Apr 8.

12.

Sex Differences in Risk Factors and Natural History of Oral Human Papillomavirus Infection.

D'Souza G, Wentz A, Kluz N, Zhang Y, Sugar E, Youngfellow RM, Guo Y, Xiao W, Gillison ML.

J Infect Dis. 2016 Jun 15;213(12):1893-6. doi: 10.1093/infdis/jiw063. Epub 2016 Feb 10.

PMID:
26908748
13.

Anal Cancer Screening in Men Who Have Sex With Men in the Multicenter AIDS Cohort Study.

DʼSouza G, Wentz A, Wiley D, Shah N, Barrington F, Darragh TM, Joste N, Plankey M, Reddy S, Breen EC, Young S, Cranston RD.

J Acquir Immune Defic Syndr. 2016 Apr 15;71(5):570-6. doi: 10.1097/QAI.0000000000000910.

14.

Prevalence of and Risk Factors for Oral Human Papillomavirus Infection among HIV-Positive and HIV-Negative People Who Inject Drugs.

Robbins HA, Fennell CE, Gillison M, Xiao W, Guo Y, Wentz A, Kirk GD, Mehta SH, D'Souza G.

PLoS One. 2015 Nov 24;10(11):e0143698. doi: 10.1371/journal.pone.0143698. eCollection 2015.

15.

Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.

Rettig EM, Wentz A, Posner MR, Gross ND, Haddad RI, Gillison ML, Fakhry C, Quon H, Sikora AG, Stott WJ, Lorch JH, Gourin CG, Guo Y, Xiao W, Miles BA, Richmon JD, Andersen PE, Misiukiewicz KJ, Chung CH, Gerber JE, Rajan SD, D'Souza G.

JAMA Oncol. 2015 Oct;1(7):907-15. doi: 10.1001/jamaoncol.2015.2524.

PMID:
26226294
16.

Oral Human Papillomavirus (HPV) Infection among Unvaccinated High-Risk Young Adults.

D'Souza G, Kluz N, Wentz A, Youngfellow RM, Griffioen A, Stammer E, Guo Y, Xiao W, Gillison ML.

Cancers (Basel). 2014 Aug 14;6(3):1691-704. doi: 10.3390/cancers6031691.

17.

Small and large size for gestational age and neighborhood deprivation measured within increasing proximity to homes.

Wentz AE, Messer LC, Nguyen T, Boone-Heinonen J.

Health Place. 2014 Nov;30:98-106. doi: 10.1016/j.healthplace.2014.08.010. Epub 2014 Sep 20.

18.

Antinociceptive effect of 3-(4-fluorophenyl)-5-trifluoromethyl-1H-1-tosylpyrazole. A Celecoxib structural analog in models of pathological pain.

Oliveira SM, Silva CR, Wentz AP, Paim GR, Correa MS, Bonacorso HG, Prudente AS, Otuki MF, Ferreira J.

Pharmacol Biochem Behav. 2014 Sep;124:396-404. doi: 10.1016/j.pbb.2014.07.005. Epub 2014 Jul 16.

PMID:
25036287
19.

Evidence of market-driven size-selective fishing and the mediating effects of biological and institutional factors.

Reddy SM, Wentz A, Aburto-Oropeza O, Maxey M, Nagavarapu S, Leslie HM.

Ecol Appl. 2013 Jun;23(4):726-41.

20.

Successful adaptation to ketosis by mice with tissue-specific deficiency of ketone body oxidation.

Cotter DG, Schugar RC, Wentz AE, d'Avignon DA, Crawford PA.

Am J Physiol Endocrinol Metab. 2013 Feb 15;304(4):E363-74. doi: 10.1152/ajpendo.00547.2012. Epub 2012 Dec 11.

21.

Water balance throughout the adult life span in a German population.

Manz F, Johner SA, Wentz A, Boeing H, Remer T.

Br J Nutr. 2012 Jun;107(11):1673-81. doi: 10.1017/S0007114511004776. Epub 2011 Sep 16.

PMID:
21920064
22.

Neurocognitive functioning of children and adolescents with mild-to-moderate chronic kidney disease.

Hooper SR, Gerson AC, Butler RW, Gipson DS, Mendley SR, Lande MB, Shinnar S, Wentz A, Matheson M, Cox C, Furth SL, Warady BA.

Clin J Am Soc Nephrol. 2011 Aug;6(8):1824-30. doi: 10.2215/CJN.09751110. Epub 2011 Jul 7.

23.

Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet.

Garbow JR, Doherty JM, Schugar RC, Travers S, Weber ML, Wentz AE, Ezenwajiaku N, Cotter DG, Brunt EM, Crawford PA.

Am J Physiol Gastrointest Liver Physiol. 2011 Jun;300(6):G956-67. doi: 10.1152/ajpgi.00539.2010. Epub 2011 Mar 31.

24.

Obligate role for ketone body oxidation in neonatal metabolic homeostasis.

Cotter DG, d'Avignon DA, Wentz AE, Weber ML, Crawford PA.

J Biol Chem. 2011 Mar 4;286(9):6902-10. doi: 10.1074/jbc.M110.192369. Epub 2011 Jan 5.

25.

Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache.

Høivik HO, Laurijssens BE, Harnisch LO, Twomey CK, Dixon RM, Kirkham AJ, Williams PM, Wentz AL, Lunnon MW.

Cephalalgia. 2010 Dec;30(12):1458-67. doi: 10.1177/0333102410370875. Epub 2010 May 12.

PMID:
20974604
26.

Adaptation of myocardial substrate metabolism to a ketogenic nutrient environment.

Wentz AE, d'Avignon DA, Weber ML, Cotter DG, Doherty JM, Kerns R, Nagarajan R, Reddy N, Sambandam N, Crawford PA.

J Biol Chem. 2010 Aug 6;285(32):24447-56. doi: 10.1074/jbc.M110.100651. Epub 2010 Jun 7.

27.

Health-related quality of life of children with mild to moderate chronic kidney disease.

Gerson AC, Wentz A, Abraham AG, Mendley SR, Hooper SR, Butler RW, Gipson DS, Lande MB, Shinnar S, Moxey-Mims MM, Warady BA, Furth SL.

Pediatrics. 2010 Feb;125(2):e349-57. doi: 10.1542/peds.2009-0085. Epub 2010 Jan 18.

28.

Sleep and fatigue symptoms in children and adolescents with CKD: a cross-sectional analysis from the chronic kidney disease in children (CKiD) study.

Roumelioti ME, Wentz A, Schneider MF, Gerson AC, Hooper S, Benfield M, Warady BA, Furth SL, Unruh ML.

Am J Kidney Dis. 2010 Feb;55(2):269-80. doi: 10.1053/j.ajkd.2009.09.021. Epub 2010 Jan 19.

29.

Antinociceptive effect of a novel tosylpyrazole compound in mice.

Oliveira SM, Gewehr C, Dalmolin GD, Cechinel CA, Wentz A, Lourega RV, Sehnem RC, Zanatta N, Martins MA, Rubin MA, Bonacorso HG, Ferreira J.

Basic Clin Pharmacol Toxicol. 2009 Feb;104(2):122-9. doi: 10.1111/j.1742-7843.2008.00353.x. Epub 2008 Dec 18.

30.

Enhanced secretion of heterologous proteins from yeast by overexpression of ribosomal subunit RPP0.

Wentz AE, Shusta EV.

Biotechnol Prog. 2008 May-Jun;24(3):748-56. doi: 10.1021/bp070345m. Epub 2008 Apr 9.

PMID:
18396911
31.

A double-blind, randomized, placebo-controlled, single-dose study of the cyclooxygenase-2 inhibitor, GW406381, as a treatment for acute migraine.

Wentz AL, Jimenez TB, Dixon RM, Aurora SK, Gold M; CXA20008 Study Investigators.

Eur J Neurol. 2008 Apr;15(4):420-7. doi: 10.1111/j.1468-1331.2008.02093.x. Epub 2008 Feb 26.

PMID:
18312401
32.

Quantifying morbidity associated with the abuse and misuse of opioid analgesics: a comparison of two approaches.

Smith MY, Schneider MF, Wentz A, Hughes A, Haddox JD, Dart R.

Clin Toxicol (Phila). 2007;45(1):23-30.

PMID:
17357378
33.

A novel high-throughput screen reveals yeast genes that increase secretion of heterologous proteins.

Wentz AE, Shusta EV.

Appl Environ Microbiol. 2007 Feb;73(4):1189-98. Epub 2006 Dec 22.

34.

Neurocognitive outcomes in children with chronic kidney disease: Current findings and contemporary endeavors.

Gerson AC, Butler R, Moxey-Mims M, Wentz A, Shinnar S, Lande MB, Mendley SR, Warady BA, Furth SL, Hooper SR.

Ment Retard Dev Disabil Res Rev. 2006;12(3):208-15. Review.

PMID:
17061289
35.

CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis.

Griffey MA, Wozniak D, Wong M, Bible E, Johnson K, Rothman SM, Wentz AE, Cooper JD, Sands MS.

Mol Ther. 2006 Mar;13(3):538-47. Epub 2005 Dec 20.

36.

Hydration status in the United States and Germany.

Manz F, Wentz A.

Nutr Rev. 2005 Jun;63(6 Pt 2):S55-62. Review.

PMID:
16028572
37.

The importance of good hydration for the prevention of chronic diseases.

Manz F, Wentz A.

Nutr Rev. 2005 Jun;63(6 Pt 2):S2-5. Review.

PMID:
16028566
38.

24-h hydration status: parameters, epidemiology and recommendations.

Manz F, Wentz A.

Eur J Clin Nutr. 2003 Dec;57 Suppl 2:S10-8. Review.

PMID:
14681708
39.

The most essential nutrient: defining the adequate intake of water.

Manz F, Wentz A, Sichert-Hellert W.

J Pediatr. 2002 Oct;141(4):587-92.

PMID:
12378203
40.

Factors affecting renal hydrogen ion excretion capacity in healthy children.

Manz F, Wentz A, Lange S.

Pediatr Nephrol. 2001 May;16(5):443-5.

PMID:
11405120
42.

Follicle stimulating hormone effects on immature human oocytes: in vitro maturation and hormone production.

Durinzi KL, Wentz AC, Saniga EM, Johnson DE, Lanzendorf SE.

J Assist Reprod Genet. 1997 Apr;14(4):199-204.

43.

Strategies for ovulation induction and oocyte retrieval in the lowland gorilla.

Hatasaka HH, Schaffer NE, Chenette PE, Kowalski W, Hecht BR, Meehan TP, Wentz AC, Valle RF, Chatterton RT, Jeyendran RS.

J Assist Reprod Genet. 1997 Feb;14(2):102-10.

44.
45.

Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of life.

Crucitt MA, Hyman W, Grote T, Tester W, Madajewicz S, Yee S, Wentz A, Griffin D, Parasuraman TV, Bryson J.

Clin Ther. 1996 Jul-Aug;18(4):778-88.

PMID:
8879903
46.

Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of life.

Crucitt MA, Hyman W, Grote T, Tester W, Madajewicz S, Yee S, Wentz A, Griffin D, Parasuraman TV, Bryson J.

Clin Ther. 1996 May-Jun;18(3):508-18. Corrected and republished in: Clin Ther. 1996 Jul-Aug;18(4):778-88.

PMID:
8829027
47.

Ondansetron for nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

DiBenedetto J Jr, Cubeddu LX, Ryan T, Kish JA, Sciortino D, Beall C, Eisenberg PD, Henderson C, Griffin D, Wentz A.

Clin Ther. 1995 Nov-Dec;17(6):1091-8.

PMID:
8750400
48.

Estrogenic and antiestrogenic activities of anordiol: a comparison of uterine and vaginal responses with those of clomiphene citrate.

Peters AJ, Wentz AC, Kazer RR, Jeyendran RS, Chatterton RT Jr.

Contraception. 1995 Sep;52(3):195-202.

PMID:
7587192
49.

TEST-yolk media and sperm quality.

Jeyendran RS, Gunawardana VK, Barisic D, Wentz AC.

Hum Reprod Update. 1995 Jan;1(1):73-9. Review.

PMID:
9080208
50.

Women's health issues.

Wentz AC.

Adv Intern Med. 1995;40:1-30. Review. No abstract available.

PMID:
7747644

Supplemental Content

Support Center